Maria Grazia Cusi Selected Research

Maria Grazia Cusi Research Topics

Disease

19	Neoplasms (Cancer) 01/2023 - 11/2002
19	Infections 01/2023 - 06/2008
8	COVID-19 01/2024 - 01/2021
6	Colorectal Neoplasms (Colorectal Cancer) 04/2018 - 04/2003
5	Human Influenza (Influenza) 01/2019 - 01/2004
5	Carcinoma (Carcinomatosis) 12/2005 - 11/2002
4	Colonic Neoplasms (Colon Cancer) 06/2012 - 07/2005
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2017
3	Meningitis 12/2019 - 07/2002
3	Breast Neoplasms (Breast Cancer) 09/2018 - 04/2003
2	Reinfection 01/2022 - 01/2022
2	Wounds and Injuries (Trauma) 12/2019 - 09/2019
2	Neoplasm Metastasis (Metastasis) 09/2017 - 11/2002
2	Fever (Fevers) 04/2016 - 09/2015
2	Rhinitis 04/2016 - 09/2015
2	Arthralgia (Joint Pain) 04/2016 - 09/2015
2	Bites and Stings (Sting) 11/2011 - 07/2008
1	Post-Acute COVID-19 Syndrome 01/2023
1	Inflammation (Inflammations) 11/2022
1	Virus Diseases (Viral Diseases) 11/2022
1	Measles 02/2020
1	Pharyngitis (Sore Throat) 09/2019
1	Myocarditis (Carditis) 01/2019
1	Cardiogenic Shock 01/2019
1	Keratitis 12/2018
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2017
1	Erythema 04/2016
1	Rectal Neoplasms (Rectal Cancer) 04/2016
1	Conjunctivitis 04/2016

Drug/Important Bio-Agent (IBA)

10	AntigensIBA 01/2024 - 04/2003
10	VaccinesIBA 02/2020 - 01/2004
9	Peptides (Polypeptides)IBA 04/2018 - 11/2002
6	Monoclonal AntibodiesIBA 01/2024 - 03/2006
6	Thymidylate SynthaseIBA 04/2018 - 10/2005
5	Immunoglobulin G (IgG)IBA 01/2021 - 06/2012
5	AntibodiesIBA 02/2020 - 11/2011
5	Proteins (Proteins, Gene)FDA Link 12/2019 - 11/2002
5	Gemcitabine FDA Link 04/2016 - 07/2005
5	Fluorouracil (Carac)FDA LinkGeneric 06/2012 - 04/2003
5	HLA-A Antigens (HLA-A)IBA 05/2008 - 11/2002
4	CytokinesIBA 01/2023 - 07/2005
4	Neutralizing AntibodiesIBA 05/2022 - 02/2020
4	EpitopesIBA 04/2018 - 05/2008
4	EnzymesIBA 04/2016 - 10/2005
4	VirosomesIBA 05/2008 - 01/2004
3	tetraphenylporphine sulfonate (TPPS)IBA 04/2018 - 09/2015
3	Interleukin-2 (IL2)IBA 04/2016 - 12/2005
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2016 - 07/2005
3	Protein Subunit VaccinesIBA 04/2016 - 05/2008
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2015 - 12/2005
3	Cancer VaccinesIBA 03/2006 - 04/2003
3	Carcinoembryonic AntigenIBA 12/2005 - 04/2003
2	Interleukin-6 (Interleukin 6)IBA 11/2022 - 01/2016
2	Glycoproteins (Glycoprotein)IBA 08/2021 - 07/2008
2	RNA (Ribonucleic Acid)IBA 01/2021 - 07/2002
2	Immunoglobulin M (IgM)IBA 01/2020 - 01/2013
2	Bevacizumab (Avastin)FDA Link 09/2017 - 09/2017
2	Cisplatin (Platino)FDA LinkGeneric 09/2017 - 09/2017
2	Etoposide (VP 16)FDA LinkGeneric 09/2017 - 09/2017
2	aldesleukin (Proleukin)FDA Link 06/2012 - 07/2008
2	Nucleic AcidsIBA 07/2011 - 01/2006
2	Parathyroid Hormone-Related ProteinIBA 05/2008 - 11/2002
2	Leucovorin (Folinic Acid)FDA Link 12/2005 - 07/2005
2	DNA (Deoxyribonucleic Acid)IBA 10/2005 - 01/2004
1	FluoroquinolonesIBA 04/2023
1	cilgavimabIBA 01/2023
1	cilgavimab and tixagevimab drug combinationIBA 01/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2023
1	remdesivirIBA 10/2022
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 09/2022
1	SARS-CoV-2 spike proteinIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	atezolizumabIBA 01/2022
1	NivolumabIBA 01/2022
1	pembrolizumabIBA 01/2022
1	avelumabIBA 01/2022
1	durvalumabIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 10/2021
1	Messenger RNA (mRNA)IBA 05/2021
1	BNT162 VaccineIBA 05/2021
1	InterleukinsIBA 11/2020
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2020
1	Measles VaccineIBA 02/2020
1	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 02/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2019
1	Propolis (Bee Bread)IBA 09/2019
1	Neuraminidase (Sialidase)IBA 01/2018
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2018
1	Endothelial Growth FactorsIBA 09/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2017
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 04/2016

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 01/2022 - 07/2005
5	Immunotherapy 04/2016 - 07/2005
2	Combination Drug Therapy (Combination Chemotherapy) 06/2012 - 12/2005
1	Off-Label Use 01/2023
1	Fecal Microbiota Transplantation 01/2022
1	Extracorporeal Membrane Oxygenation 01/2019
1	Contact Lenses 12/2018
1	Vascular Access Devices (Arterial Line) 09/2018
1	Radiotherapy 09/2017